raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:210159

Adult hepatocellular carcinoma

Synonyms: Adult HCC

Type
Disease
Group
Disorder
Inheritance
Not applicable
Age of onset
Adult, Elderly
Status
active

A rare carcinoma of the liver characterized by one to several or many nodules occurring anywhere within the liver, composed of neoplastic epithelial cells with hepatocellular differentiation. The vast majority of tumors are associated with chronic liver disease (such as hepatitis B or C, or steatohepatitis) or exposure to a variety of exogenous agents. Patients may present with signs and symptoms related to the tumor, as well as to the underlying condition. Common manifestations include right upper quadrant abdominal pain, weight loss, hepatosplenomegaly, jaundice, and ascites. Symptomatic tumors generally have poor prognosis.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enAdult hepatocellular carcinomaAdult HCC
frCarcinome hépatocellulaire de l'adulteCHC adulte · HCC adulte
deHepatozelluläres Karzinom, adultesHCC, adultes · Leberzellkrebs im Erwachsenenalter
esCarcinoma hepatocelular del adultoCHC del adulto
itCarcinoma epatocellulare dell'adultoHCC dell'adulto
nlVolwassen hepatocellulair carcinoomVolwassen HCC
ptCarcinoma hepatocelular do adultoHCC do adulto
plRak wątrobowokomórkowy dorosłychHCC dorosłych
csHepatocelulární karcinom dospělýchHCC dospělých · Rakovina jater dospělých
ukГепатоцелюлярна карцинома дорослихHCC у дорослих
zh成人肝细胞癌成人HCC
trYetişkin hepatoselüler karsinomErişkin HCC

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM114550NTBTvalidated
ICD-10C22.0NTBTattributedvalidated
ICD-112C12.02NTBTattributedvalidated
MONDO0016216Evalidated
UMLSC0279607Evalidated
GARD6608Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

9 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
CTNNB1Candidate gene tested inNot yet assessedHGNC:2514ENSG000001680361168063p22.1catenin beta 110435629[PMID]
PDGFRLCandidate gene tested inNot yet assessedHGNC:8805ENSG000001042136045848p22platelet derived growth factor receptor like7898930[PMID]_12653892[PMID]
TP53Candidate gene tested inNot yet assessedHGNC:11998ENSG0000014151019117017p13.1tumor protein p538191284[PMID]
TSC1Candidate gene tested inAssessedHGNC:12362ENSG000001656996052849q34.13TSC complex subunit 127974549[PMID]
TSC2Candidate gene tested inAssessedHGNC:12363ENSG0000010319719109216p13.3TSC complex subunit 227974549[PMID]
AXIN1Disease-causing somatic mutation(s) inAssessedHGNC:903ENSG0000010312660381616p13.3axin 110700176[PMID]
CASP8Disease-causing somatic mutation(s) inAssessedHGNC:1509ENSG000000640126017632q33.1caspase 815531912[PMID]
PIK3CADisease-causing somatic mutation(s) inAssessedHGNC:8975ENSG000001218791718343q26.32phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha15608678[PMID]
EGFMajor susceptibility factor inAssessedHGNC:3229ENSG000001387981315304q25epidermal growth factor21440548[PMID]
5

Prevalence and incidence

1 record
TypeClassValueAreaQualificationValidationSource
Annual incidence1-9 / 100 0003.22 / 100 000EuropeValue and classValidated22033323[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

Orphanet has no HPO annotation for this code in this release.

7

Sources for this card